Lapatinib alone had no effect on tumour size, weight, or volume (Fig. 5D-F, and Supplementary Fig. S4H), despite evidence of lapatinib in the blood and tumours at concentrations shown to inhibit HER2 activity and decrease viability in vitro (Supplementary Fig. S4I). The gene discussed is ERBB2; the disease is neoplasm.